Publicacións en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (32)

2024

  1. A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression

    Frontiers in Immunology, Vol. 15

  2. Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis

    International Journal of Molecular Sciences, Vol. 25, Núm. 18

2023

  1. Association of Serum Neurofilament Light Chain Levels at Disease Onset with Disability Worsening in Patients with a First Demyelinating Multiple Sclerosis Event Not Treated with High-Efficacy Drugs

    JAMA Neurology, Vol. 80, Núm. 4, pp. 397-403

  2. MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate

    Biomedicines, Vol. 11, Núm. 10

  3. Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response

    Frontiers in Immunology, Vol. 14

2022

  1. Epstein-Barr Virus Load Correlates with Multiple Sclerosis-Associated Retrovirus Envelope Expression

    Biomedicines, Vol. 10, Núm. 2

  2. Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study

    Frontiers in Immunology, Vol. 13

  3. Mitochondrial Impairments in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients

    Biology, Vol. 11, Núm. 11

  4. Short-chain fatty acids during pregnancy in multiple sclerosis: A prospective cohort study

    European Journal of Neurology, Vol. 29, Núm. 3, pp. 895-900

  5. microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate

    Frontiers in Immunology, Vol. 13

2021

  1. Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression

    Frontiers in Immunology, Vol. 12

  2. Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls

    Cells, Vol. 10, Núm. 1

2020

  1. MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients

    Frontiers in Immunology, Vol. 11

  2. Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab

    Scientific Reports, Vol. 10, Núm. 1

  3. Syncytin-1/HERV-W envelope is an early activation marker of leukocytes and is upregulated in multiple sclerosis patients

    European Journal of Immunology, Vol. 50, Núm. 5, pp. 685-694

2019

  1. Epidemiology of multiple sclerosis and vitamin D levels in Lanzarote, Canary Islands, Spain

    PeerJ, Vol. 2019, Núm. 12

2018

  1. Blood lymphocyte subsets identify optimal responders to IFN-beta in MS

    Journal of Neurology, Vol. 265, Núm. 1, pp. 24-31

  2. Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS (J Neurol, 10.1007/s00415-017-8625-6)

    Journal of Neurology

  3. Study of the possible link of 25-hydroxyvitamin D with Epstein–Barr virus and human herpesvirus 6 in patients with multiple sclerosis

    European Journal of Neurology, Vol. 25, Núm. 12, pp. 1446-1453

2017

  1. Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort

    European Journal of Clinical Investigation, Vol. 47, Núm. 2, pp. 158-166